Keywords: عامل D; Properdin; Factor B; Factor D; C9; Membrane attack complex; Alzheimer's disease; Age-related macular degeneration;
مقالات ISI عامل D (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae
Keywords: عامل D; NulO; nonulosonate; LOS; lipooligosaccharide; LNnT; lacto-N-neotetraose; Lst; LOS sialyltransferase; FH; factor H; FB; factor B; FD; factor D; MASP-2; Mannan binding lectin associated serine protease 2; FHL-1; Factor H-like protein 1; FHR-1; Factor H-rela
Lutein and Factor D: Two intriguing players in the field of age-related macular degeneration
Keywords: عامل D; Lutein; Age-related macular degeneration; Factor D; Complement system;
Alternative complement pathway component Factor D contributes to efficient clearance of tissue debris following acute CCl4-induced injury
Keywords: عامل D; Complement; Alternative pathway; Factor D; Acute liver injury; Necrosis;
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome
Keywords: عامل D; AP; alternative pathway; aHUS; atypical hemolytic uremic syndrome; CP; classical pathway; CR1; complement receptor 1; DAF; decay accelerating factor; DDD; dense deposit disease; EM; electron microscopy; FB; factor B; FD; factor D; FH; factor H; FI; factor
Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins
Keywords: عامل D; Complement; Inhibitors; Alternative pathway C3 convertase; Peptides; Surface plasmon resonance; AP; alternative pathway; CP; classical pathway; fB; factor B; fD; factor D; fI; factor I; LP; lectin pathway; MA; membrane attack complex; NMR; nuclear magneti
Aurin tricarboxylic acid self-protects by inhibiting aberrant complement activation at the C3 convertase and C9 binding stages
Keywords: عامل D; Properdin; Factor B; Factor D; Membrane attack complex; Macular degeneration; Paroxysmal nocturnal hemoglobinemia; Rheumatoid arthritis; Alzheimer disease;
Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement
Keywords: عامل D; Complement activation pathways; Collagen antibody induced arthritis; Inflammation; MBL; MASP-1; Ficolin-B; AP; alternative pathway; CAIA; collagen antibody-induced arthritis; CP; classical pathway; EGTA; ethylene glycol tetraacetic acid; FCN; ficolin(s);
Complement activation and innate immunity
Keywords: عامل D; C1q; the collagen-like first component of the classical complement activation pathway; C1r and C1s; the serine proteases that associate with C1q in the C1 complex and activate C4 and C2 by cleavage; MBL; a collagen-like mannan-binding lectin; MASP; MBL-as
CRIT peptide interacts with factor B and interferes with alternative pathway activation
Keywords: عامل D; Alternative pathway; Factor B; Complement C2 receptor inhibitor trispanning; C3 convertase; Haemolytic assay; Factor D
Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop
Keywords: عامل D; Mannan-binding lectin (MBL); Factor D; Properdin; Phagocytosis; Zymosan; Complement